Tag Archive for: pandemic influenza vaccine

NanoBio Awarded Up to $10 Million in NIH Funding to Develop a Pandemic Influenza Vaccine

Additional funding allocated to research nanoemulsion-adjuvanted HIV vaccine

ANN ARBOR, Mich., (October 29, 2013) – NanoBio Corporation today announced that the company has been awarded an initial contract worth $5.5 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop a nanoemulsion (NE) adjuvant for use with a pandemic influenza vaccine. Read more